| Dr Silpa Pk Joshi, MD | |
|
3201 Jermantown Rd Ste 250, Fairfax, VA 22030-2881 | |
| (703) 849-8440 | |
| Not Available |
| Full Name | Dr Silpa Pk Joshi |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 3201 Jermantown Rd Ste 250, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811256381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 0101261908 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
A second-generation experimental anti-obesity and diabetes drug has shown promise in reducing body weight in rodents just as effectively as the predecessor rimonabant while avoiding the risk of psychiatric side effects that led to the withdrawal of rimonabant from the market and stopped further development of other brain-penetrating drugs of its type.
Moscow Center for Diagnostics & Telemedicine and RADLogics shared the results of a large-scale study (Moscow Experiment on the Computer Vision for the Analysis of Medical Images - mosmed.ai, NCT04489992) conducted by the Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department.
What motivated Americans to wear masks and stay socially distanced (or not) at the beginning of the COVID-19 pandemic? More often than not, it was partisanship, rather than perceived or actual health risk, that drove their behavior, according to a new study co-authored by researchers at Brown University.
Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6).
Kaiser Permanente, one of the country's largest not-for-profit health plans, has been recognized as a "Best Place to Work" by three publications. In the first half of 2010, the organization was ranked No. 1 by Diversity MBA Magazine for diverse managers, and No. 2 in the San Francisco Business Times' list of "Best Places to Work."
› Verified 5 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
A second-generation experimental anti-obesity and diabetes drug has shown promise in reducing body weight in rodents just as effectively as the predecessor rimonabant while avoiding the risk of psychiatric side effects that led to the withdrawal of rimonabant from the market and stopped further development of other brain-penetrating drugs of its type.
Moscow Center for Diagnostics & Telemedicine and RADLogics shared the results of a large-scale study (Moscow Experiment on the Computer Vision for the Analysis of Medical Images - mosmed.ai, NCT04489992) conducted by the Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department.
What motivated Americans to wear masks and stay socially distanced (or not) at the beginning of the COVID-19 pandemic? More often than not, it was partisanship, rather than perceived or actual health risk, that drove their behavior, according to a new study co-authored by researchers at Brown University.
Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6).
Kaiser Permanente, one of the country's largest not-for-profit health plans, has been recognized as a "Best Place to Work" by three publications. In the first half of 2010, the organization was ranked No. 1 by Diversity MBA Magazine for diverse managers, and No. 2 in the San Francisco Business Times' list of "Best Places to Work."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Silpa Pk Joshi, MD 3201 Jermantown Rd Ste 250, Fairfax, VA 22030-2881 Ph: (703) 849-8440 | Dr Silpa Pk Joshi, MD 3201 Jermantown Rd Ste 250, Fairfax, VA 22030-2881 Ph: (703) 849-8440 |
News Archive
A second-generation experimental anti-obesity and diabetes drug has shown promise in reducing body weight in rodents just as effectively as the predecessor rimonabant while avoiding the risk of psychiatric side effects that led to the withdrawal of rimonabant from the market and stopped further development of other brain-penetrating drugs of its type.
Moscow Center for Diagnostics & Telemedicine and RADLogics shared the results of a large-scale study (Moscow Experiment on the Computer Vision for the Analysis of Medical Images - mosmed.ai, NCT04489992) conducted by the Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department.
What motivated Americans to wear masks and stay socially distanced (or not) at the beginning of the COVID-19 pandemic? More often than not, it was partisanship, rather than perceived or actual health risk, that drove their behavior, according to a new study co-authored by researchers at Brown University.
Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6).
Kaiser Permanente, one of the country's largest not-for-profit health plans, has been recognized as a "Best Place to Work" by three publications. In the first half of 2010, the organization was ranked No. 1 by Diversity MBA Magazine for diverse managers, and No. 2 in the San Francisco Business Times' list of "Best Places to Work."
› Verified 5 days ago
Shivangi Vachhani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3700 Joseph Siewick Dr Ste 408a, Fairfax, VA 22033 Phone: 877-511-4625 Fax: 703-204-9006 | |
Dr. Raymund S Cuevo, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-0241 | |
Dr. Michael Maitland, M.D., PH.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-1601 | |
Dr. Paul G. Rochmis, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3027 Javier Rd, Suite 2, Fairfax, VA 22031 Phone: 703-573-2220 Fax: 703-573-7767 | |
Aswani Kumar Suthrave, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-3600 | |
Nader H Balba, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3028 Javier Rd Ste 500, Fairfax, VA 22031 Phone: 703-698-8960 Fax: 571-494-5794 | |
Rona Harthill Earle, Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3020 Hamaker Ct Ste B102, Fairfax, VA 22031 Phone: 703-573-4072 Fax: 703-572-2153 |